Opthea

Opthea, located in South Yarra, Victoria, is dedicated to advancing vision health through innovative therapies for people suffering from vision-threatening diseases, particularly wet age-related macular degeneration (wet AMD). Their flagship product, Sozinibercept, is currently in pivotal clinical trials and aims to deliver superior visual outcomes, enhancing the quality of life for patients.

The company emphasizes the importance of superior vision for daily activities and overall well-being, with a mission to elevate the standard of care in the treatment of wet AMD. With a strong commitment to research and development, Opthea is at the forefront of pioneering solutions that have the potential to significantly improve patient independence and mental health outcomes.

Generated from the website